BU-NOT-SET

CONTACT US
Explore Recipharm's Full Service Offering
  • Corporate
Recipharm_packaging
Brochure
Successful drug development
  • Drug product
Eyes
Insight
How CDMOs can help reduce the risk of counterfeit medicines entering the supply chain
  • Manufacturing
Eyes
Insight
Tackling complexity in scale-up
  • Drug product
Lab equipment
Insight
Navigating COVID-19 – the role of CDMOs
  • Industry trends
Eyes
Insight
Best pharmaceutical dosage forms
  • Drug product
Production line
Insight
Taking an innovative approach to analytical chemistry
  • Analytical chemistry
Eyes
Insight
Recipharm and Oncopeptides collaborate in the development of Melflufen for the treatment of multiple myeloma
  • Analytical chemistry
Eyes
Insight
Excipients for orally disintegrating products
  • Drug product
Eyes
Insight
White paper
  • Biologics
Cell and virus banking in OV development and manufacturing
Insight
  • Biologics
Overcoming technical transfer challenges in virotherapy manufacturing
eBook
  • Biologics
Flexibility in gene therapy: Adapting to the unique gene therapy demands
Webinar
  • Biologics
Webinar: An optimised Plasmid DNA platform
Insight
  • Drug substance
  • Industry trends
The future of oral solid dose formulations
Insight
  • Industry trends
Trends and challenges to impact the OSD space in 2024 and beyond
Insight
  • Sustainability
Shaping pharma's carbon-reduced future
Insight
  • Sustainability
Focus on sustainability: Saving water in Bengaluru
Insight
  • Drug product
  • Drug substance
Safe handling of highly potent active pharmaceutical ingredients